Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2006
09/06/2006CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof
09/06/2006CN1829513A 5-membered heterocycle-based p-38 inhibitors
09/06/2006CN1827608A Method of purifying dibenzothiazyl disulfide
09/06/2006CN1827607A Process for preparing blue light-emitting 2-(2-hydroxy phenyl) benzothiazole chelated beryllium
09/06/2006CN1273456C Thiazole or oxazole derivatives
09/06/2006CN1273453C Intermediate for biotin and process for producing the same
09/06/2006CN1273444C Dipeptide nitriles
09/06/2006CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
09/05/2006USRE39266 5-[4-[2-[2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl]ethoxy]phenyl methyl]thiazolidine-2,4-dione; intermediate compound for antidiabetic drug
09/05/2006USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics
09/05/2006US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
09/05/2006US7102005 Diagnosing the presence or absence of polyneuropathy by assessing the presence or absence of antibodies which bind to a heparin oligosaccaride; quantitative analysis by enzyme-linked immunoabsorbent assay; kits
09/05/2006US7102000 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/05/2006US7101901 Treating Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease
09/05/2006US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
09/05/2006US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents
09/05/2006US7101533 Agent for inducing receptor potential
08/2006
08/31/2006WO2006091047A1 Thiazole derivatives as ppar delta ligands and their manufacturing process
08/31/2006WO2006090792A1 Novel haloalkylsulfonanilide derivative, herbicide, and method of use thereof
08/31/2006WO2006090698A1 Kinase inhibitor and use thereof
08/31/2006WO2006090270A1 Acid addition salt of 2-isopropyl-4-(((n-methyl)amino)methyl)thiazole and its?use in the preparation of ritonavir
08/31/2006WO2006090264A1 A process for the synthesis of 2-amino-5-protected amino-3-hydroxy-1, 6-diphenylhexane or a salt thereof - an intermediate for antiviral drugs
08/31/2006WO2006090244A1 New adamantane derivatives as dipeptidyl, peptidase iv inhibitors, processes for their preparation, and pharmaceutical compositions containing them
08/31/2006WO2006066133A3 Histone deacetylase inhibitors
08/31/2006WO2006060029A3 Insecticidal n-substituted sulfoximines
08/31/2006US20060194966 N'-{2-amino-1-(3,5-difluorobenzyl)-3-[(3-; ethylbenzyl)oxy]propyl}-N,N-dipropylisophthalamide; beta-secretase inhibitors; halts or reduces production of A beta peptide from amyloid precursor proteins and reduces or eliminates the formation of beta-amyloid deposits in the brain
08/31/2006US20060194859 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
08/31/2006US20060194854 New 2-substituted - 1,3-thiazole compounds
08/31/2006US20060194853 Alkyl benzamides
08/31/2006US20060194852 Glutaminyl based DPIV inhibitors
08/31/2006US20060194825 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/31/2006US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands
08/31/2006US20060194788 N-(5-ethyl-5-methyl-4,5,6,7-tetrahydro-benzothiazole-2-yl)-guanidine or its formate, suitable for the treatment of pain and hyperalgesia
08/31/2006US20060194768 N-(4-{2-[[3-Bromo-4-(difluoro-phosphono-methyl)-benzyl]-(3 ,4-dichloro-phenyl)-amino]-thiazol-4-yl}-phenyl)-oxalamic acid; antidiabetic, hypotensive agent; ischemia, kidney failure, atherosclerosis, metabolic syndrome, insulin resistance, leptin resistance, obesity, neurodegenerative diseases
08/30/2006EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis
08/30/2006EP1695969A1 Alpha-amino acid derivatives and use thereof as medicines
08/30/2006EP1695968A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
08/30/2006EP1695961A1 Urea derivative, process for producing the same, and use
08/30/2006EP1695705A1 Compounds effecting glucokinase
08/30/2006EP1694673A1 Novel thiazole derivates
08/30/2006EP1694657A1 Compositions comprising an hiv protease inhibitor
08/30/2006EP1694640A1 Anti-cancer agents
08/30/2006EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694329A2 Diamine and iminodiacetic acid hydroxamic acid derivates
08/30/2006EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists
08/30/2006EP1442030B1 Thiopene- amd thiazolesulfonamides as antineoplastic agents
08/30/2006EP1439885B1 Simplified sarcodictyn derivatives as anti-tumor agents
08/30/2006CN1826385A Monoazo compound and method for producing same
08/30/2006CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/30/2006CN1826309A O-coordinated metal chelates and their use in optical recording media having high storage capacity
08/30/2006CN1824658A Improvement preparation method of using 2-aminothiazole-4-acetyl chloride hydrochloride as intermediate of preparation cephalosporin
08/30/2006CN1272329C Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents
08/30/2006CN1272316C Benzamides and related inhibitors of factor Xa
08/29/2006US7098336 FXR NR1H4 nuclear receptor binding compounds
08/29/2006US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes
08/29/2006US7098228 Indolyl derivatives
08/29/2006US7098227 Disubstituted thiazolyl carboxanilides and their use as microbicides
08/29/2006US7098212 Piperazine derivatives
08/29/2006US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
08/29/2006US7098201 Heteroaromatic derivatives having an inhibitory activity against HIV integrase
08/29/2006CA2396738C Thiazole derivatives as active superoxide radical inhibitors
08/29/2006CA2240735C Process for production of piperidine derivatives
08/29/2006CA2112779C Arylsulfonamido-substituted hydroxamic acids
08/24/2006WO2006089225A1 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene] thiazolidin-2 , 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma
08/24/2006WO2006087169A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
08/24/2006WO2006066126A3 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts
08/24/2006WO2006062972A3 Heterocyclic compounds as inhibitors of factor viia
08/24/2006WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/24/2006WO2005097114A3 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
08/24/2006WO2005070042A8 Novel chemical compounds
08/24/2006US20060189810 Novel sulfonamide inhibitors of aspartyl protease
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
08/24/2006US20060189589 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease
08/24/2006US20060189583 Aryl dicarboxamides
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006CA2598087A1 5-[4-(4-(2-amino-2 methoxycarbonylethyl)phenoxy)benzilidene]thiazolidin-2,4-dione derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma
08/23/2006EP1693365A1 Inhibitors of dipeptidyl peptidase IV
08/23/2006EP1692952A2 Flavouring a foodstuff with compounds containing a sulphur atom linked to two specific atoms or groups
08/23/2006EP1692124A1 Biaryl sulfonamides as mmp inhibitors
08/23/2006EP1692121A1 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
08/23/2006EP1692120A1 Method for producing chiral mercapto amino acids
08/23/2006EP1692119A1 Methods of preparing compounds useful as protease inhibitors
08/23/2006EP1692109A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/23/2006CN1823072A Inhibitors of P38 and methods of using the same
08/23/2006CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
08/23/2006CN1271055C Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
08/22/2006US7094896 Diaminothiazoles having antiproliferative activity
08/22/2006US7094807 Viricides; hepatitis virus
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/22/2006US7094794 used for lowering the blood glucose and for the prevention and treatment of diabetes
08/22/2006US7094792 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/22/2006US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
08/22/2006CA2240927C Process for production of piperidine derivatives